William Blair Assumes Xenon Pharmaceuticals (XENE) at Outperform
Tweet
Share
E-mailGet Alerts XENE Hot Sheet
Price: $63.18 +1.31%
Rating Summary:
24 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Rating Summary:
24 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Join SI Premium – FREE
William Blair analyst Myles Minter assumes coverage on Xenon Pharmaceuticals (NASDAQ: XENE) with a Outperform rating.
For an analyst ratings summary and ratings history on Xenon Pharmaceuticals click here. For more ratings news on Xenon Pharmaceuticals click here.
Shares of Xenon Pharmaceuticals closed at $37.59 yesterday.
You May Also Be Interested In
- Freedom Capital Starts Hut 8 Mining Corp. (HUT) at Buy
- Canaccord Starts Sinda Ltd (SIND) at Spec. Buy
- BMO Capital Starts Ascendis Pharma (ASND) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
